MRNA SBC to Revenue

Moderna · SBC to Revenue

MRNA logo

MRNA SBC to Revenue

Current (TTM)15.66%
MRNA SBC/Revenue (36.31% → 15.66%)
High-resolution chart · PNG

MRNA sbc to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna SBC to Revenue — Annual fiscal periods
Period endingSBC to Revenue
24.8457%
13.4104%
4.4539%
1.1974%
0.8006%
11.5759%
134.734%
53.7248%
19.4607%
36.3113%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.